MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$103,415K
Net unrealized
gains (losses) on...
$279K
Interest income
$16,013K
Net loss
-$103,694K
Total other income
(expense), net
$15,964K
Other expense
-$49K
Loss from operations
-$119,658K
Total operating
expenses
$119,658K
Research and development
$85,856K
General and
administrative
$33,802K
Back
Back
Income Statement
source: myfinsight.com
Enliven Therapeutics, Inc. (ELVN)
Enliven Therapeutics, Inc. (ELVN)